Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome

S. Vadhan-Raj, H. E. Broxmeyer, G. Spitzer, A. LeMaistre, S. Hultman, G. Ventura, J. D. Tigaud, M. A. Cork, J. M. Trujilo, J. U. Gutterman, W. N. Hittelman

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

A complete hematologic remission was achieved in a patient with therapy-related preleukemia and transfusion-dependent pancytopenia after treatment with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). The patient remained in remission for nearly 1 year despite the discontinuation of GM-CSF treatment. Several lines of evidence suggest that normal hematopoiesis was restored after GM-CSF treatment. First, the cytogenetic anomaly, which was present before GM-CSF, completely disappeared after three cycles of treatment. Cytogenetic conversion was documented by conventional karyotypic evaluation of mitotic bone marrow cell preparations as well as by premature chromosome condensation analysis of the nonmitotic cells of bone marrow and peripheral blood. Second, the growth pattern and cycle status of bone marrow granulocyte-macrophage (CFU-GM) and erythroid (BFU-E) progenitor cells were found to be normal during remission. Third, X chromosome-linked restriction fragment length polymorphism-methylation analysis of DNA from mononuclear cells (>80% lymphocytes) and mature myeloid elements showed a polyclonal pattern. These findings suggest that restoration of hematopoiesis in this patient after GM-CSF treatment may have resulted from suppression of the abnormal clone and a selective growth advantage of normal elements.

Original languageEnglish (US)
Pages (from-to)1491-1498
Number of pages8
JournalBlood
Volume74
Issue number5
StatePublished - Jan 1 1989

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Vadhan-Raj, S., Broxmeyer, H. E., Spitzer, G., LeMaistre, A., Hultman, S., Ventura, G., Tigaud, J. D., Cork, M. A., Trujilo, J. M., Gutterman, J. U., & Hittelman, W. N. (1989). Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood, 74(5), 1491-1498.